• Home
  • About
    • About EIPG
    • The Statute
    • Bureau and Executive
      • The Past Presidents Advisory Committee
    • Member States
    • EIPG Awards
      • EIPG Award Recipients
  • Information
    • Guides and Codes
    • Position Papers
  • Education
  • Media Library
    • Presentations
    • Photo Gallery
  • News
    • From the Bureau
    • News from EIPG
    • EU Focus
    • Regulatory Affairs
    • Business & Policies
    • Technology & Research
  • Members
    • Members Area
    • Webinars
  • Contact Us
Login Area

Members Area

 

Follow Us
Facebook
Twitter
LinkedIn
YouTube
Slideshare
EIPG Logo
  • Home
  • About
    • About EIPG
    • The Statute
    • Bureau and Executive
      • The Past Presidents Advisory Committee
    • Member States
    • EIPG Awards
      • EIPG Award Recipients
  • Information
    • Guides and Codes
    • Position Papers
  • Education
  • Media Library
    • Presentations
    • Photo Gallery
  • News
    • From the Bureau
    • News from EIPG
    • EU Focus
    • Regulatory Affairs
    • Business & Policies
    • Technology & Research
  • Members
    • Members Area
    • Webinars
  • Contact Us

EIPG Comments on European Commission Public Consultation on Excipients Guidelines

The European Commission recently launched a targeted stakeholder consultation on the revised guidelines on excipients in the labelling and package leaflet of medicinal products for human use. EIPG has reviewed the document and, following feedback from its members, has submitted its comments to the European Commission.

Read the EIPG Feedback on the targeted stakeholder consultation.

  • In memory of John Jolley
    • April 24, 2025
  • EMA guideline on investigational ATMPs
    • April 24, 2025
  • The proposal of a Critical Medicines Act
    • April 4, 2025
  • EIPG Webinar | The Cumulative Impact of Environment and Chemical Legislation and the future of the Healthcare Sector | Kirsty Reid
    • March 25, 2025
  • The Clean Industrial Deal and the Omnibus package on simplification
    • March 25, 2025
  • The FDA’s Advanced Manufacturing Technologies Designation Program
    • March 9, 2025
  • The EU’s Competitiveness Compass and the new EU Biotech Hub
    • February 21, 2025
  • The EU AI Act: compliance obligations and business opportunities in 2025
    • February 17, 2025
  • PIC/S’ new guidances on remote and hybrid inspections
    • February 5, 2025
  • ICH E6(R3): a new era for Good Clinical Practice in industrial pharmacy
    • January 31, 2025
EU Transparency Register
EIPG is registered in the EU
Transparency Register with public ID
number 979567925318-36

0
0
0
33
0
Disclaimer and Privacy Policy
  • Privacy Policy
  • Disclaimer
Contacts
  • General Inquiries
  • President
  • Executive Director
  • Vice-President Communications